Solid Organ Transplant Recipients With SARS-CoV-2 French Registry

SARS-CoV-2 Clinical Trial

— TX-COVID  

Official title:

Clinical Presentation and Incidence of SARS-CoV-2 Infection in Different Cohorts of Solid Organ Transplant Patients and Follow-up in France

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04360707
• Other study ID #: 7766
• Status: Recruiting
• Start date: April 8, 2020
• Est. completion date: April 8, 2021

Study information

• Verified date: April 2020
• Source: University Hospital, Strasbourg, France
• Contact: Sophie CAILLARD, MD, PhD
• Phone: 33 3 69 55 13 20
• Email: sophie.caillard[@]chru-strasbourg.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Patients with comorbid condition are known to be at high risk of severe forms of Covid-19. It is highly probable that immunocompromised patients like solid organ transplant (SOT) recipients are also at risk of severe forms of Covid-19. For this purpose, The investigators conducted a nationwide multicentric and multiorgan Registry to collect data about all French SOT recipients who develop a SARS-CoV-2 infection. The aim is to describe the clinical, biological and virological characteristics of these patients and to give information about evolution and prognosis of these particular population

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 300
• Est. completion date: April 8, 2021
• Est. primary completion date: April 8, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 1 Year and older

Eligibility

Inclusion Criteria:

• All Solid Organ Transplant recipients with a functioning graft and a high suspicion or a confirmed SARS-CoV-2 infection

• Adult and pediatric

Exclusion Criteria:

• There are no exclusion criteria, except for the patient's explicit refusal to participate

Related Conditions & MeSH terms

• SARS-CoV-2

Locations

Country	Name	City	State
France	Service de Néphrologie et Transplantation	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Clinical Presentation and Incidence of Covid-19 Infection in Different Cohorts of Solid Organ Transplant Patients		From 1st March 2020 to 1st March 2021